Peyronie’s disease affects the penis, but many of its billing problems begin on the claim form. A single wrong diagnosis code can delay Xiaflex approval, trigger a denial, or send a surgical claim into review.
This guide explains how to report Peyronie’s disease with ICD-10-CM code N48.6. It also covers paired CPT and HCPCS codes, modifiers, documentation, payer rules, and denial prevention. Urology practices can use it to build cleaner claims from the first visit.
Understanding Peyronie’s Disease Before You Code It
Peyronie’s disease is a connective tissue disorder of the penis. Scar tissue, called plaque, forms in the tunica albuginea, the fibrous sheath around the erectile bodies. The plaque can cause curvature, pain, shortening, narrowing, or an hourglass deformity during erection.
The condition usually moves through two phases. The acute phase often lasts 6 to 18 months and involves pain and a changing curve. The chronic phase begins when the plaque and the curvature stop changing.
Phase matters for billing. Collagenase injection requires a palpable plaque and a curve of at least 30 degrees. Surgery is usually considered only after the disease has been stable for several months. The clinical note must document the phase because payers use it to judge medical necessity.
Practices that already follow a structured urology billing guide will recognize the same principle here. The diagnosis code, the procedure code, and the clinical note must tell one consistent story.
Peyronie’s Disease ICD-10 Code: N48.6
What N48.6 Represents
The ICD-10-CM code for Peyronie’s disease is N48.6. Its official title is induration penis plastica. The code sits in Chapter 14 of ICD-10-CM, which covers diseases of the genitourinary system. It is a complete, billable code and needs no extra characters.
Report N48.6 when the provider documents Peyronie’s disease or plastic induration of the penis. Do not report it from a symptom alone. A patient who reports a bent erection without an exam has not yet received a diagnosis.
Section IV.H of the ICD-10-CM Official Guidelines for Coding and Reporting bars outpatient coding of uncertain diagnoses. Terms such as “probable,” “suspected,” and “rule out” do not qualify. If the note says “possible Peyronie’s disease,” code the documented sign or symptom instead.
Related Diagnosis Codes
Peyronie’s disease rarely travels alone. Many patients also have erectile dysfunction, and some have a history of pelvic surgery or hand fibromatosis. The table below lists codes that commonly appear on the same claim.
| ICD-10-CM Code | Description | When to Use |
|---|---|---|
| N48.6 | Induration penis plastica (Peyronie’s disease) | Primary code when the provider diagnoses Peyronie’s disease |
| N52.9 | Male erectile dysfunction, unspecified | Secondary code when erectile dysfunction is documented without a known cause |
| N52.31 | Erectile dysfunction following radical prostatectomy | When erectile dysfunction follows that surgery |
| M72.0 | Palmar fascial fibromatosis (Dupuytren contracture) | When the provider documents it as an associated condition |
| Q55.61 | Curvature of penis (lateral), congenital | Congenital curvature only, never for acquired curvature |
List N48.6 first when Peyronie’s disease is the main reason for the visit or the procedure. Add erectile dysfunction as a secondary code only when the provider documents it as a separate problem.
Coding Mistakes to Avoid
Most diagnosis errors come from habit rather than a knowledge gap. Coders should watch for the following patterns.
- Using Q55.61 for acquired curvature. This code describes a congenital condition. Peyronie’s disease is acquired and belongs under N48.6.
- Sequencing erectile dysfunction first on a Peyronie’s procedure. The primary code should match the reason for the service.
- Copying a diagnosis from an old problem list. Each claim needs support from the current encounter note.
- Choosing an unspecified code when the note is specific. For other genitourinary conditions on the same claim, a reference on urology ICD-10 codes helps coders select the most specific option.
CPT and HCPCS Codes Used With Peyronie’s Disease
N48.6 explains why a service was needed. CPT and HCPCS codes describe what the provider did. The table below summarizes the most common pairings.
| Code | Description | Typical Use |
|---|---|---|
| 54200 | Injection procedure for Peyronie disease | Intralesional injection into the plaque |
| 54205 | Injection procedure for Peyronie disease; with surgical exposure of plaque | Less common injection with surgical exposure |
| J0775 | Injection, collagenase clostridium histolyticum, 0.01 mg | Xiaflex drug supply, billed in units |
| 54235 | Injection of corpora cavernosa with pharmacologic agent | Induces an erection to assess curvature |
| 93980 | Duplex scan of penile vessels, complete study | Evaluates plaque and vascular function |
| 93981 | Duplex scan of penile vessels, limited study | Focused follow-up ultrasound |
| 54110 | Excision of penile plaque | Plaque excision without graft |
| 54111 and 54112 | Excision of penile plaque with graft | Graft up to 5 cm, or greater than 5 cm |
| 54360 | Plastic operation on penis to correct angulation | Plication or tunical shortening |
| 54401 and 54405 | Insertion of inflatable penile prosthesis | Self-contained device, or multicomponent device |
| 99202 to 99215 | Office or outpatient E/M visits | Evaluation, counseling, and treatment planning |
Collagenase Clostridium Histolyticum (Xiaflex)
The FDA approved Xiaflex for Peyronie’s disease in 2013. The label covers adult men with a palpable plaque and a curvature deformity of at least 30 degrees at the start of therapy. Each cycle includes two injections, given one to three days apart, followed by penile modeling.
Providers may repeat cycles about six weeks apart, up to four cycles. Each injection visit is a separate service. Report 54200 for the administration and J0775 for the drug.
J0775 is billed per 0.01 mg. A standard Peyronie’s dose is 0.58 mg, so the practice reports 58 units for each injection. This conversion is a frequent source of error, because staff sometimes enter a single unit.
Xiaflex comes in a 0.9 mg single-dose vial. A 0.58 mg dose leaves 0.32 mg unused. Since July 2023, Medicare requires the JW modifier on the discarded amount, which is 32 units. The JZ modifier applies when no drug is discarded. Chapter 17 of the Medicare Claims Processing Manual covers drug billing rules.
Xiaflex carries a Risk Evaluation and Mitigation Strategy for Peyronie’s disease because of the risk of corporal rupture and other serious penile injury. Prescribers must hold certification, and the chart should confirm it. Payers may ask for proof during review.
Some payers require supply through a specialty pharmacy. In that case, the practice did not buy the drug and must not bill J0775. It bills only the administration and the visit. Confirm the supply method before the first injection.
Medicaid and several commercial payers also require the National Drug Code on the J0775 line. Report it with the N4 qualifier, the unit of measure, and the quantity. Confirm each payer’s policy on whether modeling is separately payable, because many bundle it into the treatment cycle.
Other Intralesional Injections
Some providers inject verapamil or interferon alfa-2b into the plaque. Practices typically report these with 54200, but payers often classify the drugs as off-label. Coverage varies widely.
Verify the payer policy before treatment. For Medicare patients, an advance beneficiary notice may be appropriate if coverage is uncertain. For commercial patients, a signed financial acknowledgment protects the practice from unexpected balances.
Diagnostic Services
Penile duplex ultrasound documents plaque size, calcification, and blood flow. Report 93980 for a complete study and 93981 for a limited one. Use modifier 26 or TC when the practice bills only one component.
Code 54235 covers the injection of a drug into the corpora cavernosa. In Peyronie’s care, it produces a rigid erection so the provider can measure curvature accurately. The note should explain why the injection was needed and record the measured angle.
Surgical Procedures
Surgery is typically reserved for stable disease with severe curvature that prevents intercourse. The choice depends on curve severity, penile length, and erectile function. Plication, grafting, and prosthesis placement each have distinct codes.
Surgical codes carry global periods. Check the Medicare Physician Fee Schedule for the period assigned to each code. An unrelated visit within a global period needs modifier 24, and an unrelated procedure needs modifier 79.
Modifiers That Affect Peyronie’s Disease Claims
Modifiers tell the payer why two services belong on the same claim. Misuse invites audits, and omission invites denials. The table below lists those most relevant to this condition.
| Modifier | Meaning | Peyronie’s Example |
|---|---|---|
| 25 | Significant, separately identifiable E/M on the same day as a procedure | Counseling and treatment planning before a 54200 injection |
| 59 or XS | Distinct procedural service | Separate services that payer edits would otherwise bundle |
| 26 | Professional component | Provider interprets a duplex ultrasound performed in a facility |
| TC | Technical component | Practice owns the equipment but does not bill the interpretation |
| JW | Drug amount discarded | 32 units of J0775 wasted from a 0.9 mg vial |
| JZ | No drug discarded | Entire vial used for the patient |
| 24 | Unrelated E/M during a postoperative period | New problem during a global period |
| 79 | Unrelated procedure during a postoperative period | Different procedure within a global period |
Modifier 25 requires its own documentation. A brief check before injection does not qualify. The note must show a distinct evaluation, such as a review of symptoms, an exam, and a treatment decision.
Documentation Requirements for Peyronie’s Disease Claims
Payers deny what the chart cannot prove. A complete note supports the diagnosis, the procedure, and the drug units. At a minimum, document these elements at the start of care.
- Onset date and duration of symptoms
- Pain level and whether pain occurs with erection
- Curvature angle in degrees and its direction
- Plaque location, size, and palpation findings
- Penile shortening, narrowing, or hinge effect
- Erectile function score, such as SHIM or IIEF
- Prior treatments and results
- Disease stability over the previous three to six months
- Informed consent, including the risk of corporal rupture
At each Xiaflex visit, add the dose, the injection site, the lot number, the expiration date, and the amount discarded. After the second injection of a cycle, record whether modeling occurred and what instructions the patient received.
A measured angle carries more weight than a description. “Dorsal curvature of 45 degrees” supports the Xiaflex criteria. “Significant curve” does not. Photographs or an in-office measurement during an induced erection strengthen the record.
Well-configured urology EMRs can reduce these gaps. Structured fields for curvature, plaque size, and drug waste prompt staff to complete each element before the visit closes. Free-text notes make the same data harder to find during an audit.
Prior Authorization and Payer Requirements
Xiaflex is a costly drug, so most payers manage it closely. Medicare covers it under Part B when medically necessary, though local coverage rules vary by contractor. Commercial plans such as Aetna, UnitedHealthcare, Cigna, Humana, and Blue Cross Blue Shield plans often require prior authorization.
Payers commonly adopt the FDA label as their policy. They look for a palpable plaque, a curve of at least 30 degrees, and a certified prescriber. Many also ask for the erectile function score and a record of prior therapy.
Submit the authorization request before the first injection, and attach the chart note. Confirm how many cycles or injections the approval covers. An authorization for one cycle does not extend to the next.
Timely filing limits also matter. Medicare allows one calendar year from the date of service. Commercial limits vary, often from 90 to 180 days, so verify each contract. A late claim for an expensive drug is rarely recoverable.
Common Denials and How to Prevent Them
Most Peyronie’s denials trace back to a small set of causes. The table below links each denial to its usual source and its fix.
| Denial Reason | Typical Cause | Prevention |
|---|---|---|
| No prior authorization | Approval was not obtained or has expired | Verify authorization at scheduling for every cycle |
| Medical necessity not met | Curvature angle or plaque not documented | Record the angle in degrees at each baseline visit |
| Diagnosis and procedure mismatch | Erectile dysfunction listed ahead of N48.6 on a 54200 claim | Sequence N48.6 first |
| Incorrect drug units | One unit billed instead of 58 | Convert milligrams to units before submission |
| Missing JW or JZ | Waste modifier omitted | Add a waste field to the charge entry process |
| Bundling edit | 54200, 54235, or an E/M billed together without support | Apply modifier 25 or 59 only with matching documentation |
Track denials by payer. A pattern at one payer often points to a policy detail the practice has missed. Review each denial within 30 days, while records and staff memory are fresh.
Step-by-Step Billing Workflow
A consistent process prevents most of the errors listed above. Follow this sequence for each Peyronie’s patient.
- Verify benefits and confirm whether the payer requires buy-and-bill or specialty pharmacy supply.
- Obtain prior authorization with the chart note, curvature angle, and prescriber certification.
- Document baseline findings and informed consent before the first injection.
- Assign N48.6 as the primary diagnosis, with secondary codes only when documented.
- Select CPT and HCPCS codes, convert drug units, and add the NDC where required.
- Apply modifiers 25, 59, JW, or JZ only when the record supports them.
- Submit within the timely filing limit and work any denial within 30 days.
Compliance Considerations
Drug claims draw audit attention. Reviewers compare billed units with the dose recorded in the chart and the waste reported on the claim. Units billed but not administered can create liability under the False Claims Act.
Code set use also follows federal rules. HIPAA transaction standards, found at 45 CFR Part 162, require valid ICD-10-CM, CPT, and HCPCS codes on electronic claims. Use the code set version in effect on the date of service.
Internal audits help. Review a sample of Peyronie’s claims each quarter. Compare the diagnosis, the units, the modifiers, and the note. Correct errors promptly, and refund overpayments within the period the payer requires.
When Outsourcing Makes Sense
Peyronie’s disease claims combine a specific diagnosis, a high-cost drug, and strict documentation rules. Smaller practices may not treat enough patients to build deep expertise. Staff turnover can also break the process.
Urology billing services can fill that gap with coders who track payer policy changes and manage prior authorizations. Practices should still hold their billing partner accountable. Ask for denial rates by payer, days in accounts receivable, and the clean claim rate.
Frequently Asked Questions
Can N48.6 and N52.9 Appear on the Same Claim?
Yes, when the provider documents both conditions. Sequence N48.6 first if Peyronie’s disease drives the service. Report N52.9 second, and only when erectile dysfunction has its own documentation.
Is 54200 Billed Once Per Cycle or Once Per Injection?
Bill it once per injection visit. A standard Xiaflex cycle has two injection visits, so each visit supports its own 54200 line and its own J0775 units.
How Many Xiaflex Cycles Can a Practice Bill?
The FDA label allows up to four cycles. Payers may approve fewer at a time, so confirm the authorization covers each cycle before treatment begins.
Conclusion
Accurate Peyronie’s disease billing starts with N48.6 and a note that supports it. From there, each service needs the correct CPT or HCPCS code, the right units, and modifiers backed by the record. Payer rules and timely filing complete the picture.
Practices that standardize documentation, verify authorizations early, and audit their own claims will see fewer denials and faster payment. The work is detailed, but it is predictable once the process is in place.
